D
Teva Pharmaceutical Industries Limited TEVA
$16.33 -$0.13-0.79%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 4.23B 4.33B 4.16B 3.82B 4.46B
Total Other Revenue -- -- -- -- --
Total Revenue 4.23B 4.33B 4.16B 3.82B 4.46B
Cost of Revenue 2.11B 2.18B 2.14B 2.05B 2.04B
Gross Profit 2.12B 2.15B 2.02B 1.77B 2.42B
SG&A Expenses 952.00M 924.00M 939.00M 886.00M 902.00M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 28.00M -19.00M -1.00M -17.00M 36.00M
Total Operating Expenses 3.34B 3.33B 3.35B 3.16B 3.21B
Operating Income 893.00M 1.00B 817.00M 660.00M 1.25B
Income Before Tax -247.00M -321.00M -245.00M -471.00M 508.00M
Income Tax Expenses 28.00M 69.00M 630.00M -52.00M 41.00M
Earnings from Continuing Operations -275.00M -390.00M -875.00M -419.00M 467.00M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 58.00M -47.00M 29.00M 280.00M -4.00M
Net Income -217.00M -437.00M -846.00M -139.00M 463.00M
EBIT 893.00M 1.00B 817.00M 660.00M 1.25B
EBITDA 1.16B 1.26B 1.08B 932.00M 1.52B
EPS Basic -0.19 -0.39 -0.75 -0.12 0.41
Normalized Basic EPS 0.42 0.36 0.34 0.48 0.56
EPS Diluted -0.19 -0.39 -0.75 -0.12 0.40
Normalized Diluted EPS 0.42 0.36 0.34 0.48 0.55
Average Basic Shares Outstanding 1.13B 1.13B 1.13B 1.12B 1.12B
Average Diluted Shares Outstanding 1.13B 1.13B 1.13B 1.12B 1.14B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings